Corcept Therapeutics (CORT) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Corcept Therapeutics Announces Third Quarter 2016 Financial Results and Provides Corporate Update
November 1, 2016 4:05 PM EDTMENLO PARK, CA -- (Marketwired) -- 11/01/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
Financial Highlights
Third quarter revenue of $21.7 million, a 64 percent increase from the third quarter of 2015 Third quarter GAAP net income of $0.02 per share, compared to a GAAP net loss of $0.01 per share in the third quarter of 2015 Excluding non-cash expenses, third quarter non-GAAP net income of $0.04 per share, compared to non-GAAP net income of $0.02 per share in the third quarter of 2015 Company increases 2016 revenue guidance to $79-82 million Cash balance at September 30, 2016 increases to... More